Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum NexgenRx Inc. V.NXG

Alternate Symbol(s):  NEGXF

NexgenRx Inc administers, adjudicates and pays drug, dental and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers using proprietary computer software and provides ancillary services. Some of the products and services of the company are Dental Claims, Prescription Drug Claims and many more.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 


-Hopefully the first of many , conservative but that is good. -Management continues to methodically build this company. -This company is undervalued at these prices . -DYOc  rate and reply

Interesting market action

- Volume multifold from benchmark on October 8/2021. -Looks like someone is intrigued with NexgenRX. -This under the radar company deserves watching. -Tightly held by long term investors . more

RE:CFO buys 40,500 shares at $.34

Insiders are scooping up shares big time at $.34  rate and reply

A few points from Q1 release

- Revenue up YoY - No CEWS - Administration Fees revenue up YoY - EBITDA margin increased from 20% to 25% YoY Great cost cutting measures this Q. Just need transaction revenue to increase once more

More good results

-"The RETIREMENT of ALL outstanding DEBT." --Growth in EBITDA and Net Profit. -Draw Your Own conclusions.  rate and reply

RE:I wish it would trade

I wouldn't worry too much about the volume - the way I see it the only way im giving up these shares is a takeover.  rate and reply

I wish it would trade

NexgenRx is stuck with a bid of 37 cents and ask of 54 cents.   It has been a few days where no one has bought or sold any shares. I find it a bit unusual.   I am holding out more

M&A in the industry

People Corporation Significantly Expands its National Advisor Network and Broadens its Client and Advisor Solution Offering Through the Acquisition of Benefits by Design more

Big moves today

up 76% today, feels like there's a new buyer out there  rate and reply

Wonderful Results

- Showing stability. - Gigantic future potential for high margin growth , meanwhile fine tuning and turning a profit. -Uniquely positioned. -Undervalued. -Increasingly becoming a Jewel coveted more


Great results for the year. This years revenue was also impacted by reduction in claims due to people staying at home and not going to dentists, chiroporactors etc. Annual revenue (not including CEWS) more


-EBITDA UP. -SALES UP in spite of COVID. -NET PROFIT UP. -COSTS DOWN. -Unique positioning in the market place. -Adaptable. -Superior Software and Functionality. -Undervalued. -What are Your more